Quantitative polymerase chain reaction for hepatitis B virus DNA

Journal of Virological Methods

Volumn 49, Issue 3, 1994, Pages 331-341

  Wu, Jianwen ^a   Sullivan, Deborah E ^a   Gerber, Michael A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Competitive PCR; HBV; Hepatitis B; Polymerase chain reaction; Virus quantification

Indexed keywords

ANTIVIRUS AGENT; CARBOCYCLIC 2' DEOXYGUANOSINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE; DEOXYGUANOSINE; DNA PRIMERS; DNA, VIRAL; HEPATITIS B VIRUS; HUMAN; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.; VIROLOGY; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 0027942529     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(94)90148-1     Document Type: Article

References (15)

1. Polymerase chain reaction strategy
2. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver
3. Transcription of the dystrophin gene in human muscle and non-muscle tissues
4. Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction
5. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction
6. A general method of in vitro preparation and specific mutagencsis of DNA fragments study of protein and DNA interactions
7. Hepatitis B viral DNA in liver and serum of asymptomatic carriers
8. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using polymerase chain reaction technique
9. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay
10. Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics
11. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
12. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine
13. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analogue of 2′-deoxyguanosine
14. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA
15. Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNA